THOMAS V. WHELAN, M.D.
To the editor: Eighty percent of patients with severe renal insufficiency have hypertension before the institution of dialysis (1). Once on maintenance dialysis, approximately 25% will still require at least one antihypertensive medication (2). In certain instances, this dialysis-resistant hypertension is due to a relative or absolute increase in renin activity. Treatment has traditionally been with beta-blockers and more recently with angiotensin-converting enzyme inhibitors. As a group, the beta-blockers are the most commonly prescribed agents for control of hypertension, and they are usually well tolerated. The most dangerous adverse reactions are well known and include congestive heart failure, aggravation of
WHELAN TV. Propranolol, Epinephrine, and Accelerated Hypertension During Hemodialysis. Ann Intern Med. ;106:327. doi: 10.7326/0003-4819-106-2-327_1
Download citation file:
Published: Ann Intern Med. 1987;106(2):327.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use